Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.43 |
| ▸ | ITGAV | P06756 | 1/20 | 0.33 |
| ▸ | ITGB6 | P18564 | 1/20 | 0.33 |
| ▸ | CCKAR | P32238 | 5/20 | 0.32 |
| ▸ | CCKBR | P32239 | 5/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.32 |
| ▸ | ALB | P02768 | 3/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16093428 | 0.98 | GLP1R (0.44) | GLP1RITGAVITGB6CCKARCCKBR | |
| SCHEMBL16408121 | 0.96 | GLP1R (0.48) | GLP1RCCKARCCKBRFOLH1 | |
| SCHEMBL12122193 | 0.96 | GLP1R (0.46) | GLP1RITGAVITGB6CCKARCCKBR | |
| SCHEMBL13034770 | 0.96 | GLP1R (0.48) | GLP1RCCKARCCKBRFOLH1 | |
| SCHEMBL13034771 | 0.96 | GLP1R (0.48) | GLP1RCCKARCCKBRFOLH1 | |
| SCHEMBL16142393 | 0.95 | GLP1R (0.42) | GLP1RCCKARCCKBR | |
| SCHEMBL16142383 | 0.95 | GLP1R (0.42) | GLP1RCCKARCCKBR | |
| SCHEMBL12981346 | 0.94 | GLP1R (0.49) | GLP1RCCKARCCKBRFOLH1 | |
| SCHEMBL16180970 | 0.92 | GLP1R (0.46) | GLP1RCCKARCCKBR | |
| SCHEMBL16218295 | 0.92 | GLP1R (0.44) | GLP1RCCKARCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9695226-B2 | Growth hormones with prolonged in-vivo efficacy | NOVO NORDISK HEALTHCARE AG (CH) | 2017-07-04 | — | — | US | disclosed |